Share Name Share Symbol Market Type Share ISIN Share Description
Microgen LSE:MCGN London Ordinary Share GB00BVVHWX30 ORD 6 3/7P
  Price Change % Change Share Price Shares Traded Last Trade
  +0.00p +0.00% 367.50p 0 01:00:00
Bid Price Offer Price High Price Low Price Open Price
365.00p 370.00p - - -
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Software & Computer Services 62.64 10.78 16.40 22.4 223.8

Microgen (MCGN) Latest News

Real-Time news about Microgen (London Stock Exchange): 0 recent articles
More Microgen News
Microgen Takeover Rumours

Microgen (MCGN) Share Charts

1 Year Microgen Chart

1 Year Microgen Chart

1 Month Microgen Chart

1 Month Microgen Chart

Intraday Microgen Chart

Intraday Microgen Chart

Microgen (MCGN) Discussions and Chat

Microgen Forums and Chat

Date Time Title Posts
10/11/200517:32MICROGEN - a MICRO-GEM?207
08/7/200319:10Microgen - its electriccccccccccccccc30
18/12/200215:06Oversold>>>>> ahead of interims24
27/6/200217:22Any Views on Microgen ?11

Add a New Thread

Microgen (MCGN) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Microgen trades in real-time

Microgen (MCGN) Top Chat Posts

exbroker: And index buyers coming to a share price near you soon!!
janeann: yes looks pretty decent to me. Somewhat subdued reaction in the share price tho!
shauney2: From Citywire Citywire AAA-rated small-cap veteran Dan Nickols has ramped up a recent run of purchases in wealth management and accounting software specialist Microgen (MCGN.L) as its shares continue to climb. Nickols increased his holding in the business from 3.8 million to just over five million shares, a stake worth £16.8 million at a share price of 334p, which has risen threefold since early last year. Most of the shares are held in his £1.1 billion Old Mutual UK Smaller Companies fund with the remainder held in his colleague Nick Williamson’s £188 million Smaller Companies Focus funds. In 2016 results Microgen chair Ivan Martin hailed ‘record numbers’ of new contracts signed in the year, driving revenue 35% higher to £43 million, and its operating margin 30% higher at 15%. While consistently rating the business a buy, analysts at Investec have struggled to keep pace with the rally, which has already outstripped a late April price target of 330p.
firtashia: Abnormally high volume traded today; whilst its a perfectly good update I didnt think it would drive such a positive response in the share price. Not complaining though.
shauney2: From citywire Old Mutual manager Nick Williamson has upped his stake in wealth management and accounting software specialist Microgen (MCGN) as its share have spiked to a post tech-bubble high. Williamson increased his investment from below a disclosable level to 5.5% of the business worth just under £9 million at a share price of 268p, the highest since April 2001. The shares are held in the £173 million Old Mutual UK Smaller Companies Focus fund. Microgen has shot up 16% this month alone, capping an 82% climb over the last 12 months. The latest leg up followed 2016 results showing revenue 35% higher at £43 million and profit 26% higher at £9.5 million. The company upped its full-year dividend 19% to 5p per share. The rally has taken it to within a sliver of Investec’s recently-confirmed 270p target price however, on a price multiple of 27 times last year’s earnings.
nspal: Does anyone have confirmed data on the price levels for performance related stock option awards to MCGN senior management? I recently read that the previous chairman's potential awards were tied into share price rises to 200p, 250p and 300p before November 2018.
simon gordon: Tech Market View - 22/10/15: Microgen finds new Chairman After reporting on a more positive half year in July, see here, Microgen, the Big Data and Financial Services software company, has issued a very brief trading update as it announces some Board changes. The company’s two major businesses are continuing to “perform in line with the Board’s expectations”, with 95% of the total expected revenue for the current year now contracted. More interestingly, the company has announced that they have found a replacement for the outgoing Chairman Martyn Ratcliffe. Ivan Martin (ex-Misys and currently Non-Exec Chairman at FDM Group and RED) will take the reins as Non-Executive Chairman after the 2015 results are announced. By that time the two MDs of the operating businesses will have formally joined the Board. The new management structure will hopefully lead to a faster pace of change across the business. The past four years have seen declining revenues and pre-tax profits and a falling share price, relieved only by the management returning large amounts of cash to shareholders. A major “strategic review” generated only a handful of small acquisitions and no visible change (see here and work back). The markets where Microgen is active are interesting, even exciting. Let’s hope that Microgen itself can generate a bit more interest in the coming years.
speedsgh: 2bluelynn - Think you may have misunderstood the situ here. Part of the company is being returned to shareholders in the form of cash. There is no option for receiving more ordinary shares instead of cash. The return of cash is being effected thro the issue of B and C shares. The only decision you have to make is whether you wish to receive the cash return via B shares (cash return will be treated as a capital gain for tax purposes) or via C shares (cash return will be treated as income for tax purposes). If you don't make an election, you will automatically be allocated C shares + the cash return will be paid out as dividend income. After the return of cash, you will hold the same number of shares in a smaller company. However, in order to maintain the share price at roughly the same level as prior to the return of cash, the company is also proposing a 7-for-9 consolidation of the ordinary shares. So, if one was to own 900 shares prior to the consolidation, post consolidation the share price would remain the same but you would own 700 shares (the difference in value between your shreholding pre/post the share consolidation is being returned to you via the Return of Cash). Hope this helps. Not sure I can explain it more simply.
2bluelynn: So is it best to take the dividend as cash ?or take the 7 for 9 shares im puzzled ? Any views out there from you clever people ... I have 7500 of these so want to make the right choice I take it once the shares are issued the share price will drop by approx 22% due to the consolidation so to a £1 ish area Any advice out there ,maybe NTrader has a view ,I seem to think he has a load of these tucked away . Many thanks in advance
speedsgh: EI - Will the return of capital not be broadly neutral seeing as there will also be a share consolidation will occur alongside the return? I note that the final dividend has been maintained at the same level as last year. Struggling to get my head around whether MCGN is a decent investment or not. Share price performance in recent yrs has been disappointing. "the Board is proposing to return to shareholders approximately £20 million in cash, equivalent to 27 pence per share, ("Return of Value") by way of a B and C share scheme ("Scheme"). The Scheme provides shareholders (other than certain overseas shareholders) with a choice of receiving the cash in the form of income or capital provided that the Return of Value is completed prior to 6 April 2015. The Return of Value will be accompanied by a proportional share consolidation to maintain broad comparability of the share price and return per share of the ordinary shares before and after the creation of the B and C shares."
Microgen share price data is direct from the London Stock Exchange
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190618 23:56:57